38
Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

  • View
    217

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Novel Influenza A (Pandemic)

H1N1Rachel Long, MT MSEd, CIC

Public Health EpidemiologistInfection Control

Page 2: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Objectives• Describe the Epidemiology of H1N1

• Identify signs and symptoms of H1N1

• Discuss ways to prevent illness from spreading

• Describe vaccines for this season

• Describe anti-virals and their use

Page 3: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Influenza OverviewStructure: 16H and 9NTerms:

– Pathogenic– Virulent

H1N1– Pathogenic (spreads easily)– Low virulence (can cause death

Page 4: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Vocabulary• Endemic

• Epidemic

• Pandemic

Page 5: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Pandemic Levels

Page 6: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Past Pandemics due to Flu• 1918: 20- 100 million deaths world wide

– 500,000 to 675,000 in US– Came in waves

• 1957: 45 million infected, 70,000 died• 1968-69: 50 million infected, 33,000 died• 1976: swine flu event/500 cases recorded

Page 7: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Differences in Seasonal and Pandemic Strain

• Age groups affected– Seasonal:

• >65 and <1 year of age• 90% of death in >65 year old group

– Pandemic H1N1: • young >5 <24 years of age• Death in adults under the age of 50 is most common• Severe disease in young otherwise healthy (ICU stays)

Page 8: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Differences in Seasonal and Pandemic Strain

• Age groups affected– Seasonal:

• >65 and <1 year of age• 90% of death in >65 year old group

– Pandemic H1N1: • young >5 <24 years of age• Death in adults under the age of 50 is most common• Severe disease in young otherwise healthy (ICU stays)

NC H1N1 Cases by Week of Report

0

20

40

60

80

100

4/11 4/18 4/25 5/2 5/9 5/16 5/23 5/30 6/6 6/13 6/20 6/27 7/4 7/11 7/18 7/25

Week Ending Date

Conf

irmed

Cas

es

Page 9: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control
Page 10: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

World Preparing for Second Wave• Monitoring in other parts of world now• Has not changed (mutated) at this time• H1N1 (Pandemic strain) is dominant • Clinical picture consistent across all countries

– Mild illness for most• Monitoring Drug Resistance

– Some found but not propagated at this time

Page 11: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

2 flu Seasons?• Regular Flu Season

• H1N1 Flu season• Could get here before vaccine• Shouldn’t be any more sever than the spring• Vaccination important for HCW

Page 12: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

ED Visits and Admissions for Influenza-Like Illness

Page 13: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

How does Flu Spread• By droplets: 3-6 feet

• Droplets are spread when:– Cough– Sneeze– Talk – Breathe

Page 14: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

* Reflects disproportionate testing of hospitalized patients

Clinical Features among NC Cases

Fever 315/323 (98%)

Cough 289/307 (94%)

Sore Throat 122/201 (61%)

Coryza 114/211 (54%)

Myalgias 123/203 (61%)

Diarrhea 38/234 (16%)

Vomiting 52/241 (22%)

Hospitalized 87/406 (21%)*

Page 15: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Spread of H1N1

• Infectious Period – For a confirmed case is 1 day prior to the cases illness onset to 7

days after onset• Close Contact

– Being within 3 feet of an ill person who is a suspected or confirmed case of H1N1 during the” infectious period”

• Clinical care givers: Use Standard Precautions for your protection as well as your patients when dealing with respiratory regardless of isolation

Page 16: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Flu Vaccine

• Inactivated virus (dead)/lasts 1 year• Many will need a seasonal (1) and H1N1 (1)• Both this year are made exactly the same way• Works by stimulating the immune system to provide

protection

Page 17: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

NationalH1N1 Vaccination Program

• H1N1 Vaccine Not Yet Available– Release date mid October 2009

• Initial Amount– 40 Million Doses During First Month

• Subsequent Weekly Production– 10 to 30 Million DosesMission will receive weekly allotments after initial

Page 18: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

High Risk Groups For H1N1 Vaccine• Pregnant women

• Children under 4 years old

• Contacts of infants less than 6 months old

• Healthcare workers

• Those aged 25 to 64 with high risk conditions

Page 19: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

H1N1 Vaccine Facts ( as of Sept 7, 2009)

• 2009 H1N1 influenza vaccines are well tolerated and induce a strong immune response in most healthy adults when administered in a single unadjuvanted 15-microgram dose

• Vaccine availability depends on several factors including manufacturing time and time needed to conduct clinical trials

• seasonal flu vaccine is not expected to protect against the 2009 H1N1 flu

• do not expect that there will be a shortage of 2009 H1N1 vaccine

• availability and demand can be unpredictable

*1976 swine flu virus and the 2009 H1N1 virus are different enough that its unlikely a person vaccinated in 1976 will have full protection from the 2009 H1N1

http://www.hhs.gov/news/press/2009pres/09/20090911a.html

Page 20: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Declination StatementMission Hospitals has recommended that I receive influenza vaccination in order to protect myself and the

patients I serve.

The reason I am choosing not to take the influenza vaccine is:(Circle all that apply)

I have gotten the vaccine in the past and it made me sick.I received the vaccine elsewhere.Fear of Gillian Barre Syndrome.

I am allergic to eggs.I never get the flu.

I acknowledge that I am aware of the following facts:Influenza is a serious respiratory disease that kills as average of36,000 persons and hospitalizes more than 200,000 persons in theUnited States per year.Influenza vaccination is recommended for me and all other healthcare workers to prevent influenza diseases and its complications, including death.If I become infected with influenza, even when my symptoms are mild, I can spread severe illness to others.I understand that the strains of virus that cause influenza infection change almost every year, which is why a different influenza vaccine is

recommended each year.I cannot get the influenza disease from the influenza vaccine.The consequences of my refusing to be vaccinated could endanger my health and the health of those with whom I have contact, including:

Patients at Mission Hospitals My FamilyMy Co-workers My Community

Despite these facts, I am choosing to decline influenza vaccination right now.

Mission Hospital will require either vaccination or sign

declination statement

Page 21: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Flu MythsSome common myths that are NOT true include:

Myth 1: "The flu shot will give you the flu.“

Myth 2: "The flu shot does not work.“

Myth 3: "The flu shot makes me sick.”

Myth 4: "I never get sick, so I don't need to get vaccinated

Page 22: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Fall 2009: What toExpect in the Workplace

Absenteeism

• H1N1 Illness is now in the general population– Up to 30% of Population (according to CDC)• 50 to 100 Million People will get

H1N1 Will Have a Greater Affect on Workforce Population• We are expecting a 10‐Fold Increase in

Absenteeism at the Pandemic’s Peak

Page 23: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Mission Informationwww.missionhospitals.org

Page 24: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control
Page 25: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Visitation Limited at 2% ILI Activity in State

Policy number: 200.096

H1N1 fluis widespread

For our patients’ health – and yours – please:

Visit only if you are immediate family or patient’s caregiver

No teens or children Do not visit if you are sick

Wash your hands frequentlyThank you for helping prevent the

spread of flu.

September 7, 2009

Page 26: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

If you are Sick with H1N1 flu• Stay home : • 24 hours after their fever is gone (without the use of fever-reducing medicine). A fever

is defined as having a temperature of 100 degrees Fahrenheit or 37.8 degrees Celsius or greater.

• Get plenty of rest; • Drink clear fluids (such as water, broth, sports drinks, electrolyte beverages for infants)

to keep from getting dehydrated (loosing too much fluid);

• Cover coughs and sneezes; • Clean hands with soap and water or an alcohol-based hand rub often, especially after

using tissues and after coughing or sneezing into hands;

• Avoid close contact with others, including staying home from work or school; and

• Be watchful for emergency warning signs that might indicate you need to seek medical attention

Page 27: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Signs of Severe Illness

Pediatric1. Tachypnea2. Blue or Grey Skin color3. Not Drinking enough fluids4. Alterations in mental

status5. Irritability beyond normal6. Fever with rash7. Flu symptoms that

improve and then return

Adult• Difficulty breathing or

shortness of breath• Chest pain or pressure• Sudden dizziness• Altered Mental Status• Severe or persistent

vomiting

Page 28: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Antiviral Uses• Treatment: timing critical first 48 hours of

symptoms.– Everyone does not need Tamiflu who has

Influenza…• hcw with direct patient care who is high risk • Ill person with co-morbitidies

• Prophylaxis: Prevention/Post Exposure timing (1-2 days)

Page 29: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Face Mask and Respirator Use

• Droplet/Contact until test comes back• Droplet for confirmed A or confirmed H1N1

• Except for aerosol generating procedures– Use N-95 or PAPR..this includes

• collection of specimen• Suctioning• Nebulizer Treatment• Respiratory specimen• Intubation• Bronchoscopy

Page 30: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Website for Division of Public Health Information

http://flu.nc.gov/epi/gcdc/H1N1flu.html

Page 31: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control
Page 32: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Patient Information

Page 33: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Nursing Policy 5.08: Nasopharyngeal Specimens

Collection Steps1. Explain procedure to

patient2. Have needed supplies/PPE3. Place head slightly tilted

back 4. Have patient blow nose to

remove mucous (no snot)

Page 34: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control
Page 35: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control
Page 36: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

NC State Lab Influenza Virus Testing Results by MMWR Week, 2008–2009

Influenza Positive Tests Reported by the N.C. State Laboratory of Public Health by Week

0

10

20

30

40

50

60

70

80

40 41 42 43 44 45 46 47 48 49 50 51 52 53 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

MMWR Week

#Pos

itive

Spe

cim

ens

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

% P

ositi

ve†

Seasonal A (H1) Seasonal A (H3) A unsubtypable* Seasonal B Novel A (H1N1) Percent Positive†

Page 37: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

Accuracy of Flu Screens• Accuracy Depends Upon Prevalence• The positive and negative predictive values vary considerably

depending upon the prevalence of influenza in the community.• False-positive (and true-negative) influenza test results are more

likely to occur when disease prevalence is low, which is generally at the beginning and end of the influenza season.

• False-negative (and true-positive) influenza test results are more likely to occur when disease prevalence is high, which is typically at the height of the influenza season.

• Viral Panels do not guarantee identification of H1N1• Flu Screens are only 50% sensitive for H1N1

Page 38: Novel Influenza A (Pandemic) H1N1 Rachel Long, MT MSEd, CIC Public Health Epidemiologist Infection Control

It’s a “FARES” Event• Fluid• And • Rapidly • Evolving • Situation